These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6501546)

  • 1. The clinical utility of the dementia rating scale for assessing Alzheimer patients.
    Vitaliano PP; Breen AR; Russo J; Albert M; Vitiello MV; Prinz PN
    J Chronic Dis; 1984; 37(9-10):743-53. PubMed ID: 6501546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical validity of the Mattis Dementia Rating Scale in staging Alzheimer's dementia.
    Shay KA; Duke LW; Conboy T; Harrell LE; Callaway R; Folks DG
    J Geriatr Psychiatry Neurol; 1991; 4(1):18-25. PubMed ID: 2054047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brazilian version of the Mattis dementia rating scale: diagnosis of mild dementia in Alzheimer's disease.
    Porto CS; Fichman HC; Caramelli P; Bahia VS; Nitrini R
    Arq Neuropsiquiatr; 2003 Jun; 61(2B):339-45. PubMed ID: 12894264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Dementia Rating Scale performance and neurocognitive domains in Alzheimer's disease.
    Knox MR; Lacritz LH; Chandler MJ; Munro Cullum C
    Clin Neuropsychol; 2003 May; 17(2):216-9. PubMed ID: 13680428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boston Naming Test in Alzheimer's disease.
    Williams BW; Mack W; Henderson VW
    Neuropsychologia; 1989; 27(8):1073-9. PubMed ID: 2797414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for Mild Cognitive Impairment Using the Dementia Rating Scale-2.
    Springate BA; Tremont G; Papandonatos G; Ott BR
    J Geriatr Psychiatry Neurol; 2014 Jun; 27(2):139-44. PubMed ID: 24578462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of structure and discriminative power of the Mattis Dementia Rating Scale.
    Hofer SM; Piccinin AM; Hershey D
    J Clin Psychol; 1996 Jul; 52(4):395-409. PubMed ID: 8842876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of age, education, and gender on the Mattis Dementia Rating Scale performance of elderly Chinese and American individuals.
    Chan AS; Choi MK; Salmon DP
    J Gerontol B Psychol Sci Soc Sci; 2001 Nov; 56(6):P356-63. PubMed ID: 11682589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale.
    Cullum CM; Saine K; Chan LD; Martin-Cook K; Gray KF; Weiner MF
    Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(2):103-8. PubMed ID: 11417663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Greek demented and nondemented subjects on the Greek version of the Mattis Dementia Rating Scale. A validation study.
    Katsarou Z; Bostantjopoulou S; Zikouli A; Kazazi E; Kafantari A; Tsipropoulou V; Kourtesi G; Peitsidou E
    Int J Neurosci; 2010 Nov; 120(11):724-30. PubMed ID: 20942587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical utility of the Mattis Dementia Rating Scale in assessing cognitive decline in Alzheimer's disease.
    Miller JM; Pliskin NH
    Int J Neurosci; 2006 May; 116(5):613-27. PubMed ID: 16644521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of the dementias of Alzheimer's and Parkinson's disease with the dementia rating scale.
    Paolo AM; Tröster AI; Glatt SL; Hubble JP; Koller WC
    J Geriatr Psychiatry Neurol; 1995 Jul; 8(3):184-8. PubMed ID: 7576044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mini-Mental State Examination and Mattis Dementia Rating Scale performance differs in Hispanic and non-Hispanic Alzheimer's disease patients.
    Hohl U; Grundman M; Salmon DP; Thomas RG; Thal LJ
    J Int Neuropsychol Soc; 1999 May; 5(4):301-7. PubMed ID: 10349293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical validity of the Mattis Dementia Rating Scale in detecting Dementia of the Alzheimer type. A double cross-validation and application to a community-dwelling sample.
    Monsch AU; Bondi MW; Salmon DP; Butters N; Thal LJ; Hansen LA; Wiederholt WC; Cahn DA; Klauber MR
    Arch Neurol; 1995 Sep; 52(9):899-904. PubMed ID: 7661728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Planning and activities of daily living in Alzheimer's disease and frontotemporal dementia].
    Piquard A; Derouesné C; Lacomblez L; Siéroff E
    Psychol Neuropsychiatr Vieil; 2004 Jun; 2(2):147-56. PubMed ID: 15683978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayer-activities of daily living scale in mild and moderate dementia of the Alzheimer type.
    Nagaratnam N; Nagaratnam K; O'Mara D
    Am J Alzheimers Dis Other Demen; 2013 Dec; 28(8):784-9. PubMed ID: 24005851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct cognitive profiles of cortical and subcortical dementia in advanced illness.
    Paulsen JS; Butters N; Sadek JR; Johnson SA; Salmon DP; Swerdlow NR; Swenson MR
    Neurology; 1995 May; 45(5):951-6. PubMed ID: 7746413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confrontation naming does not add incremental diagnostic utility in MCI and Alzheimer's disease.
    Testa JA; Ivnik RJ; Boeve B; Petersen RC; Pankratz VS; Knopman D; Tangalos E; Smith GE
    J Int Neuropsychol Soc; 2004 Jul; 10(4):504-12. PubMed ID: 15327729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A brief Spanish-English equivalent version of the Boston Naming Test: a Project FRONTIER study.
    Jahn DR; Mauer CB; Menon CV; Edwards ML; Dressel JA; O'Bryant SE
    J Clin Exp Neuropsychol; 2013; 35(8):835-45. PubMed ID: 23998641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Alzheimer's Disease Assessment Scale: findings from a low-education population.
    Liu HC; Teng EL; Chuang YY; Lin KN; Fuh JL; Wang PN
    Dement Geriatr Cogn Disord; 2002; 13(1):21-6. PubMed ID: 11731711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.